Clinical Trial Update: A Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZYD1, Following Subcutaneous Administration in Healthy Volunteers [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated the safety, tolerability, and pharmacokinetics of ZYD1 following subcutaneous administration in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• ZYD1

Snippet

Sponsor: Zydus Lifesciences Limited | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED